期刊文献+

增液汤治疗干燥综合征临床观察 被引量:10

下载PDF
导出
摘要 目的观察中药增液汤治疗干燥综合征(SS)的临床疗效。方法将52例SS患者随机分为对照组和治疗组各26例。治疗组给予中药增液汤口服,对照组给予白芍总苷口服,疗程12周,观察两组患者治疗前后临床症状及实验室指标的变化情况。结果治疗12周后,治疗组总有效率(92.31%)明显优于对照组(73.08%);两组患者在血沉、C反应蛋白(CRP)、类风湿因子(RF)、免疫球蛋白IgG、IgA、IgM、唾液流率和Schirmer试验等方面较治疗前均有明显改善,且两组差值比较治疗组在血沉、CRP、RF、IgG、唾液流率和Schirmer试验方面改善均较对照组差异有显著性。对照组不良反应发生率(23.08%)明显多于治疗组(3.85%)(P<0.05)。结论中药增液汤治疗PSS能明显改善患者口干、眼干等症状,具有良好的临床疗效,且不良反应较小。
作者 申洪波
出处 《中国医刊》 CAS 2013年第7期94-96,共3页 Chinese Journal of Medicine
  • 相关文献

参考文献6

二级参考文献17

  • 1孙丽英,吴晓丹.增液汤化裁治疗原发性干燥综合征46例临床观察[J].中医药信息,2007,24(5):49-50. 被引量:9
  • 2Vitali C, Palombi G, Baldini C,et al. Sjoigren' s Syndrome DiseaseDamage Index and disease activity index: scoring systems for the as- scssmcnl of disease damage and disease activity in SjiSgren' s syn- drome, derived frnm an analysis of a cohort o1 Italian patients[J]. Arthritis Rheum, 2007,56: 2223 - 2231.
  • 3Bowman SJ, Sutcliffe N, lsenberg DA, et al. Sjoggren' s Systemic Clinical Activity Index (SCAI)-a systemic disease activity measure for use in elinieal trials in priming' Sjoigren' s syndrome [J]. Rheu- matology ( Oxford), :2007, 46:1845 - 1851.
  • 4BarD' R.I, Sutcliffe N, lsenberg DA, et al. The Sjiogren' s Syndrome Damage Index-a damage index for use in clinical trials and observa- tional studies in primary Sjogren' s syndrxme [ J ]. Rheumatology (Oxford) , 2008,47:1193 - 1198.
  • 5Seror R, Ravaud P, Mariettc X, et al. EULAR Sjiigren' s Syndrome Palicnt Reported hntex (ESSPRI) : development of a consensus pa- lient index fbr primary Sjtigren' s syndrome [J]. Ann Rheum Dis, 2011 ,70:968 - 972.
  • 6Scror R, Ravand P, Bowman SJ,et al. EULAR Sjoigren' s syndrome disease activity index: development of a consensus systemic disease activily index for primary Sjsgren' s syndrome[ J]. Ann Rheum Dis, 2010,69: 1103 - 1109.
  • 7Seror R, Mai'iette X, Bowman S, et al. Accurate detection of chan- ges in disease activity in primary Sjogren' s syndrome by the Europe- an League Against Rheumatism Sjogren' s Syndrome Disease Activity Index[ J]. Arthritis Care Res ( Hoboken), 2010,62:551 -558.
  • 8Campar A, Isenberg DA. Primary Sj6gren's syndrome activity and dam- age indices compmrison[J ]. EurJ Clin Invest, 2010,40:636-644.
  • 9Seror R, Bootsma H, Bowman SJ, et al. Outcome measures for pri- mary Sjogren' s syndrome[ J ]. J Autoimmun, 2012,23 : [ Epub a- head of print] .
  • 10Birnbaum J. Peripheral nervous system manifestations of Sjogren' s syndrome: clinical patterns, diagnostic paradigms, etiopathogenesis, and therapeutic strategies [ J ]. Neurologist, 2010,16:287 - 297.

共引文献228

同被引文献234

引证文献10

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部